Brief introduction：First generics in Chinese market, deemed to have completed the Quality Consistency Evaluation; Indicated in adults and pediatric patients 6 months and older for the: 1. Management of mild to moderate pain and the management of moderate to severe pain as an adjunct to opioid analgesics; 2. Reduction of fever.
Add: No.8, Xiyuan Ave., Hi-tech District, Chengdu, 611731, China
This website does not publish the product information of narcotic drugs, psychotropic drugs, toxic drugs for medical use, radioactive drugs, drug rehabilitation drugs and preparations of medical institutions.|
Copyright ? 成都苑東生物制藥股份有限公司 ALL Rights Reserved互聯網藥品信息服務資格證編號：(川)-非經營性-2021-0036